We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+871.56%
AUM
$992B
AUM Growth
-$120B
Cap. Flow
-$16.9B
Cap. Flow %
-1.71%
Top 10 Hldgs %
27.94%
Holding
3,085
New
108
Increased
1,637
Reduced
1,059
Closed
107

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.45B
2
JPM icon
JPMorgan Chase
JPM
+$2.22B
3
TEAM icon
Atlassian
TEAM
+$2.08B
4
NVDA icon
NVIDIA
NVDA
+$1.81B
5
AAPL icon
Apple
AAPL
+$1.67B

Sector Composition

Rank Sector Weight
1 Technology 26.79%
2 Healthcare 17.2%
3 Consumer Discretionary 15.17%
4 Financials 10.75%
5 Communication Services 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPAA icon
2376
Motorcar Parts of America
MPAA
$200M
$447K ﹤0.01%
25,076
+400
+2% +$6.75K
RTL
2377
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$444K ﹤0.01%
56,162
+2,505
+5% +$20.3K
CLNE icon
2378
Clean Energy Fuels
CLNE
$353M
$443K ﹤0.01%
55,803
+12,799
+30% +$86.2K
ARCT icon
2379
Arcturus Therapeutics
ARCT
$406M
$440K ﹤0.01%
16,322
+1,283
+9% +$32.7K
PW
2380
Power REIT
PW
$2.58M
$440K ﹤0.01%
1,116
-110
-9% -$62.7K
UEIC icon
2381
Universal Electronics
UEIC
$68.4M
$438K ﹤0.01%
14,008
+1,361
+11% +$47.1K
JNCE
2382
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$437K ﹤0.01%
64,309
+54,115
+531% +$386K
HFWA icon
2383
Heritage Financial
HFWA
$1.15B
$435K ﹤0.01%
17,375
-1,417,205
-99% -$36.2M
TBPH
2384
DELISTED
Theravance Biopharma
TBPH
$434K ﹤0.01%
45,408
+4,347
+11% +$42.6K
PTRA
2385
DELISTED
Proterra Inc. Common Stock
PTRA
$434K ﹤0.01%
57,700
+26,000
+82% +$211K
PJT icon
2386
PJT Partners
PJT
$3.82B
$433K ﹤0.01%
6,860
+440
+7% +$28.6K
EBIX
2387
DELISTED
Ebix Inc
EBIX
$433K ﹤0.01%
13,067
+18
+0.1% +$562
BIPC icon
2388
Brookfield Infrastructure
BIPC
$4.32B
$431K ﹤0.01%
8,571
+2,292
+37% +$105K
MVBF icon
2389
MVB Financial
MVBF
$389M
$431K ﹤0.01%
10,383
+4,807
+86% +$193K
OCFC icon
2390
OceanFirst Financial
OCFC
$1.62B
$431K ﹤0.01%
21,446
+1,249
+6% +$27.8K
OCGN icon
2391
Ocugen
OCGN
$349M
$430K ﹤0.01%
130,242
+2,609
+2% +$9.17K
ALX
2392
Alexander's
ALX
$1.27B
$428K ﹤0.01%
1,669
+241
+17% +$62.1K
NOG icon
2393
Northern Oil and Gas
NOG
$2.48B
$427K ﹤0.01%
15,157
+1,970
+15% +$48.3K
CSV icon
2394
Carriage Services
CSV
$494M
$426K ﹤0.01%
7,984
-280
-3% -$14.8K
AHCO icon
2395
AdaptHealth
AHCO
$756M
$425K ﹤0.01%
26,538
+13,089
+97% +$235K
FUBO icon
2396
FuboTV Inc
FUBO
$287M
$425K ﹤0.01%
5,394
+811
+18% +$94.6K
TVTX icon
2397
Travere Therapeutics
TVTX
$5.78B
$425K ﹤0.01%
16,486
+2,289
+16% +$60.8K
XPEV icon
2398
XPeng
XPEV
$9.57B
$425K ﹤0.01%
15,400
– –
HSKA
2399
DELISTED
Heska Corp
HSKA
$425K ﹤0.01%
3,077
+215
+8% +$30.4K
AMSF icon
2400
AMERISAFE
AMSF
$438M
$424K ﹤0.01%
8,530
+1,354
+19% +$69.1K

Similar funds

T. Rowe Price Associates's Q1 2022 Portfolio in Review

As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.

T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
  • T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
  • T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
  • T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
  • T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
  • T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
  • T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.

Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.